SCHEMBL797902

SCHEMBL797902

CCCCCc1nc2c(N3CCN(C(=O)COc4ccc(Cl)cc4)CC3)nc([AsH2])nc2s1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 2/20 0.53
POLB P06746 2/20 0.46
MAPT P10636 5/20 0.44
HPGD P15428 2/20 0.44
RAB9A P51151 1/20 0.44
LMNA P02545 5/20 0.43
MAPK1 P28482 1/20 0.43
ENPP2 Q13822 5/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GPR183 P32249 1/20 0.43
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NOD2 Q9HC29 1/20 0.41
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
HTT P42858 1/20 0.40
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1694203 0.92 PI4KB (0.46) PI4KBPOLBMAPTHPGDLMNA
SCHEMBL652287 0.90 PI4KB (0.66) PI4KBPOLBMAPTHPGDRAB9A
SCHEMBL655473 0.82 PI4KB (0.55) PI4KBPOLBMAPTHPGDLMNA
SCHEMBL654259 0.79 PI4KB (0.62) PI4KBPOLBMAPTHPGDRAB9A
SCHEMBL655488 0.78 PI4KB (0.62) PI4KBPOLBMAPTHPGDRAB9A
SCHEMBL1720077 0.77 PI4KB (0.57) PI4KBPOLBMAPTHPGDRAB9A
SCHEMBL654772 0.77 PI4KB (0.64) PI4KBPOLBMAPTHPGDRAB9A
SCHEMBL654617 0.77 PI4KB (0.66) PI4KBPOLBMAPTHPGDRAB9A
SCHEMBL654583 0.77 PI4KB (0.66) PI4KBPOLBMAPTHPGDRAB9A
SCHEMBL656634 0.76 PI4KB (0.70) PI4KBPOLBMAPTHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP claimed
WO-2012035423-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-03-22 WO claimed